Melanie Solomon | Investor Relations |
Ming Hsieh | Chief Executive Officer |
Brandon Perthuis | Chief Commercial Officer |
Paul Kim | Chief Financial Officer |
Lawrence Weiss | Chief Medical Officer |
Dan Leonard | Credit Suisse |
David Westenberg | Piper Sandler |
Andrew Cooper | Raymond James |
Hello and welcome to the Fulgent Genetics Q2 2023 Earnings Conference Call and Webcast. [Operator Instructions] A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded.
It's now my pleasure to turn the call over to Melanie Solomon, Investor Relations for Fulgent. Please go ahead, Melanie.